SunPower PT Raised to $16.00 (SPWR)

SunPower (NASDAQ: SPWR) had its target price raised by Citigroup from $12.00 to $16.00 in a research note issued to investors on Thursday. The firm currently has a buy rating on the stock.

Shares of SunPower opened at 11.84 on Thursday. SunPower has a one year low of $3.71 and a one year high of $13.88. The stock’s 50-day moving average is currently $9.44. The company’s market cap is $1.412 billion.

A number of other analysts have also recently weighed in on SPWR. Analysts at Lazard Capital Markets raised their price target on shares of SunPower from $11.00 to $15.00 in a research note to investors on Tuesday, February 19th. They now have a buy rating on the stock. Separately, analysts at Deutsche Bank raised their price target on shares of SunPower from $6.00 to $9.00 in a research note to investors on Friday, February 8th. They now have a hold rating on the stock. Finally, analysts at UBS AG raised their price target on shares of SunPower from $6.50 to $8.50 in a research note to investors on Friday, February 8th. They now have a neutral rating on the stock.

Three equities research analysts have rated the stock with a buy rating, ten have assigned a hold rating, one has given an underweight rating, and four have given a sell rating to the company. SunPower has an average rating of hold and an average target price of $9.69.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Google Spends $1 Billion To Purchase Waze
Google Spends $1 Billion To Purchase Waze
Apple Exploring Options In Net Radio
Apple Exploring Options In Net Radio
Taxpayers Pay Millions for Fed Workers Student Loan Relief
Taxpayers Pay Millions for Fed Workers Student Loan Relief
Aaron Hernandez, New England Patriots Player has House Searched
Aaron Hernandez, New England Patriots Player has House Searched
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Car Sales in Europe Hit Record Lows
Car Sales in Europe Hit Record Lows


Leave a Reply

 
© 2010-2013 Zolmax.com, LLC.
Subscribe Subscribe